2006
DOI: 10.1007/10_017
|View full text |Cite
|
Sign up to set email alerts
|

Engineering Cells for Cell Culture Bioprocessing – Physiological Fundamentals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
60
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 59 publications
(62 citation statements)
references
References 187 publications
2
60
0
Order By: Relevance
“…To increase productivity, many cellular pathways including energy metabolism, cell cycle, apoptosis and protein secretion have been extensively studied (Chen et al 2001;Kim and Lee 2002;Watanabe et al 2002;Ifandi and Al-Rubeai 2005;Seth et al 2006;Jayapal et al 2007;Kim et al 2012). Increasing cell density by either reducing apoptosis (Meents et al 2002;Figueroa et al 2007) or altering cell metabolism (Chen et al 2001) can lead to increase in product titers.…”
Section: Introductionmentioning
confidence: 99%
“…To increase productivity, many cellular pathways including energy metabolism, cell cycle, apoptosis and protein secretion have been extensively studied (Chen et al 2001;Kim and Lee 2002;Watanabe et al 2002;Ifandi and Al-Rubeai 2005;Seth et al 2006;Jayapal et al 2007;Kim et al 2012). Increasing cell density by either reducing apoptosis (Meents et al 2002;Figueroa et al 2007) or altering cell metabolism (Chen et al 2001) can lead to increase in product titers.…”
Section: Introductionmentioning
confidence: 99%
“…Mammalian cells have the unique ability to produce therapeutic proteins with oligosaccharides attached to their serine/threonine (O-linked glycosylation) or asparagines (N-linked glycosylation) residues (Butler 2005;Seth et al 2006a). The functional biological activity of the glycoprotein is directly affected by glycosylation, including its trafficking and folding within the host cell (Scallon et al 2006;Walsh and Jefferis 2006;Willey 1999).…”
Section: Optimisation Of Glycosylation Patternsmentioning
confidence: 99%
“…Once secreted, solubility, aggregation, stability and immunogenicity of the protein may be affected by its glycosylation pattern (Kobata 1992;Sinclair and Elliott 2005;Willey 1999;Wyss and Wagner 1996). N-glycosylation is initiated in the ER, and O-glycosylation can be initiated in either the ER or Golgi apparatus, but due to processing inconstancies glycans can have frequent structural heterogeneities (Patel et al 1992;Seth et al 2006a;Varki 1998). The most common therapeutic monoclonal antibody approved biopharmaceutical is of the immunoglobulin G (IgG) class (Walsh and Jefferis 2006).…”
Section: Optimisation Of Glycosylation Patternsmentioning
confidence: 99%
See 2 more Smart Citations